Developments in dementia treatments
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab

A Westminster Hall debate on women's health is scheduled for Thursday 27 February 2025 at 3:00pm. The debate will be led by Helena Dollimore MP.
Women's Health (165 KB , PDF)
Women live longer than men but spend more of their lives living with illness and disability. Women experience poorer health outcomes than men in several healthcare areas. Conditions like endometriosis, fibroids, and menopause also significantly impact women’s health, with long wait times for diagnosis and treatment exacerbating issues. The economic impact of women’s health conditions is substantial, costing the UK economy an estimated £11 billion annually.
The term ‘women’s health’ is used here to refer to the health of people who were registered as female on their birth certificate; this may include trans men and some non-binary people.
Access to healthcare and health outcomes vary among women. Inequalities include higher risks of pregnancy complications and cancer diagnosis delays for minority ethnic women, and significant health disparities for women in poverty, some LGBTI women, women with disabilities, and those with lower education levels.
In 2021, the Conservative government launched a call for evidence on women’s healthcare experiences, leading to the first Women’s Health Strategy for England. Key priorities identified included gynaecological conditions, fertility, menopause, menstrual health, and mental health. Many women reported not being listened to by healthcare professionals. The government published a vision for the strategy in December 2021, emphasising a life course approach and five key themes: healthcare policies, information and education, workplace health, research, and women’s voices.
Published in August 2022, the ten-year Women’s Health Strategy for England aims to improve health outcomes and how the healthcare system listens to women. It includes a six-point plan focusing on:
The strategy includes commitments like appointing a Women’s Health Ambassador, investing in research and encouraging the establishment of local women’s health hubs.
In January 2024, the Conservative government set priorities including addressing problem periods, women’s health research, and support for abuse victims. The Labour government, in January 2025, committed to reducing gynaecology waiting lists, tackling maternity care inequalities, supporting local women’s health hubs, and improving NHS performance.
As of December 2024, there were 586,013 incomplete pathways for gynaecology services in the NHS.
The NHS waiting times standard is that 92% of those on the waiting list at any given time should have been waiting for less than 18 weeks. In December 2024, 44.6% of patients waiting for gynaecology services had been waiting over 18 weeks.
The NHS also has a zero-tolerance policy for waits of over 52 weeks. As of December 2024, 18,859 patients had been waiting for gynaecology services over 52 weeks.
A 2021 briefing by the House of Lords Library summarized some of the health inequalities experienced by women:
The report also highlighted the disproportionate effect of these inequalities on Black and Asian women.
A 2022 survey found that women spent months or years waiting for a diagnosis or referral, and struggled to access services locally. Women also said their health condition affected their experience in the workplace.
Women's Health (165 KB , PDF)
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab
On 8 July 2025, there will be a Commons debate on alcohol and cancer. The debate will be led by Cat Smith MP. The Library will publish a briefing ahead of the debate.
A debate on children's health is scheduled to take place in the House of Commons Chamber on Thursday 10 July 2025. The subject for the debate was determined by the Backbench Business Committee, and the debate will be led by Dr Simon Opher MP.